_autologous-msc-ntf-cells-may-activate-neuroprotective-and-immunomodulatory-pathways.jpg "Autologous MSC-NTF Cells May Activate Neuroprotective and Immunomodulatory Pathways from immunomodulatory therapy Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 33 sec
✓ Published: 16-Apr-2019
✓ Published: 16-Apr-2019
Description:
BrainStorm Cell Therapeutics (NASDAQ: BCLI) is a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases. BrainStorm’s NurOwn® technology platform differentiates a patient’s own bone marrow-derived mesenchymal stem cells to create autologous mesenchymal stem cells secreting neurotrophic-factors (MSC-NTF cells).The autologous MSC-NTF cells are injected into the patient’s cerebrospinal fluid through intrathecal administration where th
BrainStorm Cell Therapeutics (NASDAQ: BCLI) is a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases. BrainStorm’s NurOwn® technology platform differentiates a patient’s own bone marrow-derived mesenchymal stem cells to create autologous mesenchymal stem cells secreting neurotrophic-factors (MSC-NTF cells).The autologous MSC-NTF cells are injected into the patient’s cerebrospinal fluid through intrathecal administration where th
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_immunomodulators-part-1-immunosuppressants.webp "Professor Dave Explains")
_mesenchymal-stem-cells-in-cell-and-gene-therapy-the-immunomodulatory-properties-of-mscs.webp "PromoCell")
⏲ 2 minutes 26 seconds 👁 1.8K
_proven-benefits-of-probiotics-during-pregnancy-and-breastfeeding.webp "Can Probiotics Really Treat Lactational Mastitis? nLactational mastitis is an infection of one or more lobules of the mammary gland, occurring up to 33% of lactating mothers. Although the condition may happen at any point during the lactation period, between 75-95% of cases occur within the first 12 weeks, with the frequency particularly higher during the second and third weeks postpartum. nnNew research shows that lactational mastitis is a dysbiotic process. Significant levels of beneficial mic")
_immunomodulatory-drugs.webp "Myeloma UK")
_immunomodulators-part-1-immunosuppressants.jpg)
_mesenchymal-stem-cells-in-cell-and-gene-therapy-the-immunomodulatory-properties-of-mscs.jpg)
_proven-benefits-of-probiotics-during-pregnancy-and-breastfeeding.jpg)
_immunomodulatory-drugs.jpg)
![[+]](/images/menu.gif){kind=small}